Gladius Capital Management’s Medtronic MDT Stock Holding History

Gladius Capital Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-5,100	Closed	-$528K	–	313
2021 Q4	$528K	Sell	5,100 -2,300	-31%	-$266K	0.04%	109
2021 Q3	$928K	Hold	7,400	–	–	0.07%	56
2021 Q2	$919K	Sell	7,400 -179,800	-96%	-$22.6M	0.09%	62
2021 Q1	$22.1M	Buy	187,200 +21,600	+13%	+$2.53M	0.83%	30
2020 Q4	$19.4M	Buy	165,600 +136,700	+473%	+$15M	0.96%	31
2020 Q3	$3M	Buy	+28,900	New	+$2.9M	0.3%	49
2020 Q2	–	Sell	-23,300	Closed	-$2.1M	–	84
2020 Q1	$2.1M	Sell	23,300 -9,600	-29%	-$1.02M	0.22%	48
2019 Q4	$3.73M	Buy	32,900 +11,700	+55%	+$1.28M	0.24%	68
2019 Q3	$2.3M	Buy	+21,200	New	+$2.21M	0.11%	114
2019 Q2	–	Sell	-6,300	Closed	-$574K	–	175
2019 Q1	$574K	Hold	6,300	–	–	0.03%	112
2018 Q4	$573K	Buy	+6,300	New	+$589K	0.03%	109

Other funds holding MDT

WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Gladius Capital Management's MDT Position: Q1 2022 in Review

Gladius Capital Management sold out of Medtronic (MDT) in Q1 2022, closing a stake of 178 shares — an estimated $19K sold.

Gladius Capital Management first reported a position in MDT in Q4 2018 and held it in 10 quarters. The position peaked at $1.01M in Q1 2020. 2,101 funds tracked by Wall St. Rank hold MDT as of Q1 2022.

Gladius Capital Management reported no remaining Medtronic position as of Q1 2022 after selling out during the quarter.
Gladius Capital Management sold 178 Medtronic shares in Q1 2022, an estimated $19K.
Gladius Capital Management first reported a position in Medtronic in Q4 2018 and held it in 10 quarters.
Gladius Capital Management's Medtronic position peaked at $1.01M in Q1 2020.
2,101 funds tracked by Wall St. Rank held Medtronic as of Q1 2022.

Based on Gladius Capital Management's 13F filing for Q1 2022, filed 29 Apr 2022.